Ambry Genetics
Ambry Genetics provides a wide array of genetic tests for various health conditions and offers unique programs like the Patient for Life Program and CARE Program™. The company operates a state-of-the-art Super Lab and is part of REALM IDx, Inc., collaborating with various partners to advance genetic testing and healthcare.
Genetic Testing Services
Ambry Genetics offers a comprehensive range of genetic tests covering hereditary cancer, heart conditions, neurological conditions, and rare conditions. The company provides +RNAinsight® concurrent DNA/RNA testing for more accurate DNA variant detection and classification. Additionally, their CustomNext-Cardio® test allows for a customizable panel of up to 167 genes for inherited cardiovascular or lipid disorders.
Patient for Life Program
Ambry Genetics’ Patient for Life Program includes proactive reanalysis of exome data in light of new gene-disease discoveries at no additional cost to the patient. This program aims to ensure patients benefit from the latest scientific advancements without incurring further expenses, enhancing the long-term value of their genetic testing services.
CARE Program™
The CARE Program™ at Ambry Genetics is designed to identify patients at increased risk for certain health conditions. It provides comprehensive patient education and facilitates efficient test ordering and result reporting. This program aims to support both patients and healthcare providers in managing hereditary health risks more effectively.
Super Lab Facility
Ambry Genetics operates a CLIA/CAP-certified Super Lab, a 60,000 square foot state-of-the-art facility that enhances efficiency, precision, and quality in genetic testing. The Super Lab is designed to reduce the potential for human error, ensuring high reliability in test results and fostering innovation in genetic testing technologies.
Sector Collaboration and Data Sharing
Ambry Genetics collaborates with academic, corporate, and pharmaceutical partners to expand its growing database and bring new products to market. As a committed data-sharing entity, Ambry is a leading contributor to ClinVar and GenCC, promoting transparency and collaboration in the genetic testing community. These efforts are part of the company's broader mission to empower individuals with advanced genetic solutions and transform healthcare outcomes globally.